CDC recommends telehealth visits to prepare for the possibility of a bigger outbreak of the coronavirus, which could impact encounters in direct to consumer telehealth systems. The impact will depend on the severity of the coronavirus which may result in accelerating investments in remote care systems and services. (more…)
Briefing on Personalized Medicine
Personalized medicine is an evolving field where physicians use diagnostic tests to determine which medical treatments will work best for each patient. By combining data from tests with an individual’s medical history, circumstances, and values, healthcare providers can develop targeted treatments and prevention plans. (more…)
$1 Million Prize to Target Disease
NIH’s https://www.nih.gov has launched a $1 million Technology Accelerator Challenge (TAC) to spur the design and development of non-invasive handheld digital technologies. (more…)
BARDA’s Actions on the Virus
The HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) https://www.phe/gov is working with Sanofi Pasteur, the vaccines global business unit of Sanofi https://www.sanofi.com. (more…)
Using Telemedicine in Patient Care
The report “Strategic Choice in Developing Telemedicine Observations from Three Organizations” was developed by the RUPRI Center for Rural Health Policy Analysis (RUPI) at the University of Iowa http://www.public-health.uiowa.edu/rupi with support by the Federal Office of Rural Health Policy within HHS. (more…)
News: Oregon Health Authority
The Oregon Health Authority Authority reports that counties within the state, tribes, and community partners are using a 2019 legislative investment of $5.6 million for 2019-2021 to continue modernizing the state’s public health system. The goal is to expand interventions to prevent and respond to emerging disease threats. (more…)
CHNG’s Management Review
Credit Suisse’s https://www.credit-suisse.com post quarterly conference call with Change Healthcare’s (CHNG) https://www.changehealth.com management, discussed further details on the loss of a major contract, business performance by segment, expectations over the deal with McKesson (MCK), and expectations for FY20 & FY21. (more…)